chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Severe bilateral hip pain/along with other joint pains such as knees and ankles.; This is a spontaneous report from a contactable other hcp (patient). A 24-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), Formulation: Solution for injection in pre-filled syringe Batch/Lot Number: FF2588), dose 2 intramuscular, administered in Arm Left on 01Sep2021 (At the age of 24 years old) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included anxiety, depression and covid-19 from an unknown date and unknown if ongoing. Concomitant medications included sertraline hydrochloride (ZOLOFT) taken for an unspecified indication, unspecified date; bupropion hydrochloride (WELLBUTRIN) taken for an unspecified indication, unspecified date; lorazepam (ATIVAN) taken for an unspecified indication, unspecified date. Previously patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), Formulation: Solution for injection in pre-filled syringe Batch/Lot Number: FC3180), dose 1 intramuscular, administered in Arm Left on 11Aug2021 (At the age of 24 years old) as DOSE 1, SINGLE for covid-19 immunization. The patient was not pregnant during vaccination. The patient did not take other vaccine in four weeks. Other medications in two weeks: Prescribed Wellbutrin SR 150 mg every morning, Zoloft 75 mg every morning and Ativan 0.5 mg two times per day. On 01Sep2021 patient experienced severe bilateral hip pain, along with other joint pains such as knees and ankles. The patient underwent lab tests and procedures which included sars-cov-2 test: negative on 10Sep2021 covid test type post vaccination was Nasal Swab covid test name post vaccination, Cephid covid test date on 10Sep2021 and covid test result was Negative. The outcome of the events was not recovered on an unspecified date.  Follow-up attempts are completed. No further information is expected.
pt recv vax & exp joint & muscle pain for six wk; No further details were provided;
Information has been received from a physician concerning a child who was vaccinated with a dose of MMR II/ varicella Virus Vaccine live (upgrade process). Subsequently, the patient developed swelling at the injection site. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
Pt states she had a reaction approximately 24 hours after first Hepatits B vaccination. The pt reported developing diffuse hives involving her entire face but no other areas, including the vaccination site.
Cough, headache, body aches, sweats, stomach ache, red at the site.
This spontaneous case was reported by a consumer and describes the occurrence of PRURITUS (A little itch after first dose) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001AQ1A) for COVID-19 vaccination. No Medical History information was reported. On 01-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced PRURITUS (A little itch after first dose). At the time of the report, PRURITUS (A little itch after first dose) outcome was unknown. Not Provided. mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged. Concomitants were not provided. Treatments were not provided. This case was linked to US-MODERNATX, INC.-MOD-2021-064273 (E2B Linked Report). Reporter did not allow further contact; Sender's Comments: US-MODERNATX, INC.-MOD-2021-064273:Crosslinked case dose 2.
Erythema, swelling  and heat at injections site, seen by PCP with prescription of antibiotics, improving after onset of treatment
huge area of discoloration behind my right knee and up the back of my thigh.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8733) via an unspecified route of administration in the arm left on 02Apr2021 at 13:30 as a single dose for COVID-19 immunisation. Medical history included migraine and anxiety. Concomitant medications included rizatriptan benzoate (MAXALT) from unknown date for migraine, an unknown if on going and sambucus nigra (ELDERBERRY GUMMIES) from unknown date for an unknown indication, unknown if on going. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient  had no known allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the left arm on 12Mar2021 at 13:30 as a single dose for COVID-19 immunisation. On an unknown date in 2021, the patient experienced, huge area of discoloration behind her right knee and up the back of her thigh. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the event huge area of discoloration behind  right knee and up the back of  thigh was recovering at time of this report.   No follow-up attempts are needed. No further information is expected.
Recently had an accident; Not feeling very well; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer reported for a male patient (reporters uncle).   A male patient of an unspecified age received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for Injection, Batch/Lot number: unknown) via an unspecified route of administration on an unspecified date as FIRST DOSE, SINGLE for covid-19 immunisation. The patient medical history and concomitant medications were not reported. As per report it was reported that the patient was scheduled to take 2nd dose of covid vaccine but just recently had an accident. The patient was not feeling very well after visiting the hospital. The reporter would like to know if appointment can be rescheduled. The outcome of the events was unknown.  Information on batch/lot number has been requested.
Patient was nervous about getting the vaccine. She said she had a fear of needles. After getting the vaccine she felt dizzy, warm, and sick to her stomach. An ambulance was called. Her husband came in later and said that she had a panic attack
The pt developed a rash and fever X 1 wk. In the past at 2 and 4 months, the pt had the same prolonged rash X 2 weeks at the site of vaccination. Every vaccine caused a rash that lasted 2 weeks.
Patients husband states she had high fever and sore arm. Per patient's husband symptoms were worse the evening immediately following the shot and were improving by morning. Reported the day after shot when he was asking for OTC recommendations for symptoms.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 68-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 22Jan2021 as dose 1, single (Lot number: el9262), in left arm, on 12Feb2021 as dose 2, single (Lot number: en6200), in right arm, in Sep2021 as dose 3 (booster), single (Batch/Lot number: unknown), in left arm and on 09May2022 as dose 4 (booster), single (Batch/Lot number: unknown), in right arm for covid-19 immunisation. The patient's relevant medical history included: "hypothyroid" (unspecified if ongoing). Concomitant medication(s) included: LEVOTHYROXINE, start date: May2007. Past drug history included: Welbutrin, reaction(s): "known allergies: Welbutrin". The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 12Aug2022, outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (12Aug2022) Positive. Therapeutic measures were taken as a result of vaccination failure, covid-19; COVID 19 Treatment included PAXLOVID from 12Aug2022 to 17Aug2022. The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
Started with pain on location of injection. Then next day was on the shoulder and neck. Since then I have been having severe migraines, elevated blood pressure, light headed, faint chills, and flu.
Two days of pain at the site of injection beginning 4 hours after injection. 52 hours after injection feeling of headache, fatigue, chills, swollen throat. Interrupted sleep for two nights after injection, each night with vivid dreams.
technician administered Pfizer booster dose 25 days earlier than 6 month CDC recommendation, patient stated no reaction, did vaers because company still wants us to do one
Arm became red, swollen, warm to touch. Resident became weak and had an episode of unresponsiveness. Sent to hospital on 10/16/04 from long term care facility. Diagnosis: Left upper arm cellulitis. Discharge Summary received on 1/13/20005 states lab test abnormal.
Adacel that was administered to patients after it underwent a temperature excursion of 30 degrees F/NO AE; Initial information was received on 03-Sep-2020 regarding an unsolicited valid non-serious case from a other health professional .  This case involves a 54 year old male patient who received DIPHTHERIA-2/TETANUS/5 AC PERTUSSIS VACCINE [ADACEL] (lot C5667AA, expiry date-26-Sep-21) after it underwent a temperature excursion of 30 degrees Fahrenheit on 24-Aug-2020 for prophylactic vaccination.  Medical history, medical treatment(s), vaccination(s), concomitant medication and family history were not provided.   It was a case of an actual medication error due to incorrect product storage.  At the time of report, no adverse event was reported.  This suspected adverse reaction report is submitted and classified as a medication error solely and exclusively to ensure the marketing authorization holder's compliance with the requirements set out . The classification as a medical error is in no way intended, nor should it be interpreted or construed as an allegation or claim made by the marketing authorization holder that any third party has contributed to or is to be held liable for the occurrence of this medication error.
24 hours after the injection my breasts started swelling and I developed fever up to 102F. Also very fatigued.
Pt noticed redness with TTP to left deltoid today 15SEP11. Pt was seen by Occ Hlth for tx.
headache; Chills; tired; weak; nauseated; This is a spontaneous report from a contactable consumer (patient). A 29-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot Number: EN5318), via an unspecified route of administration, administered in left arm on 16Feb2021 as single dose for COVID-19 immunization. Patient was 29 years old at the time of vaccination. On 26Jan2021 at 08:00 am patient received first dose of Bnt162b2 (lot number- EN5318, vaccine location=right arm). The patient medical history and concomitant medications were not reported. Patient had no known allergies. Patient did not test positive for Covid prior to vaccination. Patient did not receive any other vaccine in four weeks. On 16Feb2021 17:00 the patient experienced headache, chills, tired, weak and nauseated. The outcome of the events was recovered.
Redness and arm felt hot yesterday, more redness and continues to feel hot to touch today.
Information has been received from a registered nurse concerning a 87 year old patient who on 04-FEB-2011 was vaccinated with a dose of VARIVAX (Merck) (lot number 666854/0163Z) instead of ZOSTAVAX (Merck) due to a human error. There was no adverse effect reported. This is one of several reports from the same source. Additional information has been requested.
48 hours post-injection thumb on opposite side of the injection became swollen and stiff. There was no trauma to the thumb. No other joints are swollen or stiff. The joint is more swollen, stiff and painful 1 week later (1/20/21), leading to a video visit with PCP who recommended alternating heat and ice, and continued use of NSAID as needed.
Patient had an asthma attack about 5 minutes after the vaccine. The patient was able to use her rescue albuterol inhaler several times and was able to stop wheezing. Patient also  started sweating and used an ice pack
Patient had red abscess to left thigh where injection was given. Abscess occurred about 2 weeks after injection. Same event occured at 4 month vaccines, except to right thigh where pediarix and Hib were given in that thigh. no fever.
Pt received PPV23 in office and called to report redness, swelling, and pain at injection site 4 hours later. Patient stated the swelling and pain made it difficult to raise her left arm above her shoulder. Denied SOB, fever or hives. RN in office advised 600mg ibuprofen and ice as tolerated. Case discussed with Dr. who agreed with RN plan of care. Patient called back to office morning of 3/5/2018 and stated that over the weekend the swelling had spread from her upper arm to her chest. Pt stated she felt nauseated but denied any additional symptoms. Swelling, redness, and pain dissipated by PM 3/5/2018 and completely resolved by 3/6/2018. Follow-up phone call made to patient 3/9/2018 where patient stated she had been previously vaccinated with PPV23 1/2017 from old PCP. Both patient and provider unaware of previous vaccination at the time of 3/2/2018 injection.
"Covid arm"; severe pain, swelling, redness, itchiness at injection site, large bump appx. 4 inches in diameter, warm to the touch
24 hours after injection, rash appeared at injection site. Looked like hives, spread to both arms, legs and belly. Did not treat.
Devel significant fever (104) moderately sever local rxn; 4-5in induration & greater erythema upper left arm;
pt recvd vax; w/in 4hrs of vax, pt exp back pain & achy chest & diarrhea; MD said symptoms not related to vax but a commonly occuring viral illness;
Information has been received from a nurse concerning a 50 year old female with no pertinent medical history and no known drug reactions/allergies who on 17-MAR-2010 was vaccinated subcutaneously with a 0.5 ml dose of MMR II (lot # 665980/1367Y) at the back of her left arm. On 12-APR-2010 the patient had a lump on her left arm at the injection site. The patient went to a doctor's office and was told it was an allergic reaction. The nurse stated that they made appointment for the patient on 12-APR-2010, but she did not keep the appointment. There was no lab diagnostics studies performed. At the time of the report, the outcome was unknown. Additional information has been requested.
patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion); This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) in a 64-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On an unknown date, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) and PRODUCT TEMPERATURE EXCURSION ISSUE (patients have been administered doses while the temperature excursion assessment was ongoing (possible temperature excursion)) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Reporter stated that because their facility was not been able to download the digital data logger, they have been put on hold at the movement and were not administering the Moderna COVID-19 vaccine to the patients until an assessment was made. The reporter also stated that there had been no power outages that would have impacted the Moderna vaccine. The reporter stated that however, because their facility was unable to download the digital data logger, they treated this issue as a temperature excursion. It was also reported that the data logger which was unable to download was for the months of Dec-2021, Jan-2022 and Feb-2022. Reporter stated that no adverse reactions were reported by any patients.  No concomitant medications were reported.  No treatment medications were reported.
I started to have running nose on 02/04, followed by headaches, dry cough, fever on 02/05 and 02/06, rashes on the injection site and back on 02/07 and is still going on. fever lasted for 2 days, so did headaches and dry cough. running nose was just one day. I used tylenol and steroid cream.
Information has been received from a nurse concerning an unspecified number of females who were vaccinated with their second or third dose of GARDASIL. Subsequently the patients experienced episodes of prolonged arm pain. At the time of this report, the outcomes were unknown. Attempts are being made to obtain additional identifying information to distinguish the individual patients mentioned in its report. Additional information will be provided if available.
This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient. A female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose number unknown, single for Covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: NODULE (hospitalization), outcome "unknown", described as "Developed a knot underneath her arm". The patient underwent the following laboratory tests and procedures: mammogram: unknown result. The patient reported that, she developed a knot underneath her arm and was currently at the hospital to get a second mammogram relative to the knot. The lot number for bnt162b2 was not provided and will be requested during follow up.
Received vaccines 3-8-17. Stated yesterday morning, 3-28-17 had pain in (L) knee. Stated around lunchtime, had (R) ankle pain and stiffness. Started by the afternoon, both wrists were hurting. Pt reported that pain and stiffness has continued today and has had (R) index finger and knee swelling. Stated hasn't had to seek medical attention.
Eye irritation and drainage along with rhinorrhea a few minutes after the injections. Redness, swelling, and itching of left arm which progressed the next week to an oblong shaped area approximately 7 x 4 inches surrounding the injection site.
On May 30, 1998 the pt developed clinical varicella with greater than 50 itchy lesions, characterized by fatigue and headache.
Received flu vaccine at 06:45 on 09/21/15 1 hr later hive noted on left side of face. No other symptoms. BENADRYL 25mg po given with effect. Examined in ED cortisone given returned to work.
Around 12 hours after vaccination, I spiked a temp of 103.5. I had chills, nausea, and body aches. My heart rate also stayed in the 140s. I also have a large grapefruit sized red welp on my arm at the site of injection. I am currently having palpitations frequently and more than 36 hours after vaccines continue to spike a low grade temp.
This spontaneous report as received from a pharmacist refers to an 83 year old male patient. The patient's medical history included chicknepox. Patient had no drug reactions/allergies. On 23-JUL-2014 the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiration date, dose and route were unknown). No concomitant medication was reported. On 24-JUL-2014, the patient sought medical attention by calling pharmacy and reported headache, warmth of head, face and an unspecified part of his body and redness. No treatment was given for the events. No lab diagnostics studies performed. The outcome of the events was reported as not recovered/not resolved. Additional information has been requested.
10/12/2021 at 1:15 am Sharp Left ear pain, left jaw pain, neck pain chest pain extreme pounding of the left side of heart sharp left wrist pain, extreme itching then noticed new eczema rash left arm and left axilla enlarged painful burning lymph node. Sharp right knee pain and left and right big toes. Chest pain began to pierce through to left side of back when inhaling and exhaling. Blood pressure 190s over 120s and blood sugars in high 200s low 300s blood pressure, and insulin medication not working. Chest pain never went away Tylenol and Ibuprofen did not work and blood pressure continued to be high. 10/12/2021 Notified PCP at 11 am. PCP replied on 10/13/2021 at 8:30 am giving instructions to go to Urgent Care went to Urgent care and ECG had inverted T waves paramedics called.  1st admission 10/13/2021-10/15/2021 2nd Admission 10/17-10/19/2021
Patient received moderna vaccine and while waiting started to have tingling of tongue, had to be taken to the ER.